Dr. Darrin Morrissey:

It is about providing evidence of the need to increase investment, of who to target and of how to target. For us, it is a question of having a balanced portfolio. However, we have made a submission to the Department of Health for increased funding across our entire budget, including CTI. That submission is under review. I hope that there will be a step in our 2019 allocation towards a phased reversal of the original cuts. That said, and to address the Deputy's opening question, this is not just about cash. Rather, it is about the complexity of funding and, as Ms Mulroe, Ms Power and Professor Hennessy have mentioned, the blend of support on the other side of the line in terms of infrastructure, people supports and people to deliver the trials, for example, better and more flexible staffing within hospitals to allow for more research time. It is a complex blend overall and is not just about the direct funding of research. Its indirect component also needs to be factored in.